The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders & a Lead Plaintif...
July 21 2017 - 12:54PM
Business Wire
The Klein Law Firm announces that a class action complaint has
been filed on behalf of shareholders of Sinovac Biotech Ltd.
(NASDAQ:SVA) who purchased shares between April 30, 2013 and May 16,
2017. The action, which was filed in District of New Jersey,
alleges that the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class
Period, defendants made materially false and/or misleading
statements and/or failed to disclose that (1) Defendant Weidong
Yin, Sinovac’s Chairman and CEO, bribed a member of the Chinese
Food and Drug Administration to assist Sinovac’s vaccine clinical
trial and approval; (2) Yin's conduct would subject Sinovac to
heightened regulatory scrutiny; and (3) subsequently, Sinovac’s
public statements were materially false and misleading at all
relevant times.
Shareholders have until September 1, 2017 to petition the
court for lead plaintiff status. Your ability to share in any
recovery does not require that you serve as lead plaintiff. You may
choose to be an absent class member.
If you suffered a loss during the class period and wish to
obtain additional information, please contact Joseph Klein, Esq. by
telephone at 212-616-4899 or visit
http://www.kleinstocklaw.com/pslra-sb/sinovac-biotech-ltd?wire=2.
Joseph Klein, Esq. is an experienced attorney and has also
practiced as a Certified Public Accountant. Mr. Klein represents
investors and participates in securities litigations involving
financial fraud throughout the nation. Attorney advertising. Prior
results do not guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170721005527/en/
The Klein Law FirmJoseph Klein, Esq., 212-616-4899Fax:
347-558-9665www.kleinstocklaw.com
Sinovac Biotech (NASDAQ:SVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sinovac Biotech (NASDAQ:SVA)
Historical Stock Chart
From Apr 2023 to Apr 2024